Sodium Hydroxide → 6-((S)-1-(tert-butoxy)-2-ethoxy-2-oxoethyl)-7-(7-fluoro-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)-5-methylpyrazolo[1,5-a]pyrimidine-2-carboxylic acid
反応式
[C:1]([O:5][C@@H:6]([C:12]1[C:13]([CH3:37])=[N:14][C:15]2[N:16]([N:29]=[C:30]([C:32]([O:34]CC)=[O:33])[CH:31]=2)[C:17]=1[C:18]1[C:27]([F:28])=[CH:26][C:21]2[O:22][CH2:23][CH2:24][NH:25][C:20]=2[CH:19]=1)[C:7]([O:9][CH2:10][CH3:11])=[O:8])([CH3:4])([CH3:3])[CH3:2].[OH-].[Na+]>CCO>[C:1]([O:5][C@@H:6]([C:12]1[C:13]([CH3:37])=[N:14][C:15]2[N:16]([N:29]=[C:30]([C:32]([OH:34])=[O:33])[CH:31]=2)[C:17]=1[C:18]1[C:27]([F:28])=[CH:26][C:21]2[O:22][CH2:23][CH2:24][NH:25][C:20]=2[CH:19]=1)[C:7]([O:9][CH2:10][CH3:11])=[O:8])([CH3:4])([CH3:2])[CH3:3]参加物
反応物 2
生成物 1
試薬・触媒・溶媒 1
実験手順
To a solution of ethyl 6-((S)-1-(tert-butoxy)-2-ethoxy-2-oxoethyl)-7-(7-fluoro-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)-5-methylpyrazolo[1,5-a]pyrimidine-2-carboxylate (130 mg, 0.253 mmol) in EtOH (4 mL) was added 1N NaOH (0.303 mL, 0.303 mmol) and the resulting mixture was stirred at room temp for 4 h. At this point LCMS indicated completion of reaction. The reaction mixture concentrated and the residue diluted with water (3 mL), acidified with 1N HCl, extracted with ethyl acetate (25 mL), washed with brine (10 mL), dried (Na2SO4), filtered and concentrated to afford 6-((S)-1-(tert-butoxy)-2-ethoxy-2-oxoethyl)-7-(7-fluoro-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)-5-methylpyrazolo[1,5-a]pyrimidine-2-carboxylic acid (110 mg, 0.226 mmol, 89% yield) as off-white solid (mixture of mono and diacid and also atrope isomers) which was used as is in the next step without further purification. LCMS (M+H)=487.3.
後処理
- customcompletion of reaction
- concentrationThe reaction mixture concentrated
- additionthe residue diluted with water (3 mL)
- extractionextracted with ethyl acetate (25 mL)
- washwashed with brine (10 mL)
- dry with materialdried (Na2SO4)
- filtrationfiltered
- concentrationconcentrated
出典と根拠
- ORDレコード
- ord-610e9881c93c4342a41413306fd14993
- 出典データセット
- uspto-grants-2014_07
- 特許番号
- US08791108B2
反応ノート
読み込み中…